Cystic fibrosis: An inherited susceptibility to bacterial respiratory infections

Molecular Medicine Today

Volumn 5, Issue 8, 1999, Pages 351-358

  Tümmler, Burkhard ^a   Kiewitz, Claudi ^b  

^a Department of Biochemistry ^*

^b HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; BACTERIAL VACCINE; DEFENSIN; PYOCIN; TRANSMEMBRANE CONDUCTANCE REGULATOR;

AEROSOL; BACTERIAL INFECTION; BACTERIAL VIRULENCE; BURKHOLDERIA CEPACIA; CALORIC INTAKE; CYSTIC FIBROSIS; EXOCRINE GLAND; HAEMOPHILUS INFLUENZAE; HOST RESISTANCE; HUMAN; IMMUNOTHERAPY; INFECTION SENSITIVITY; ION TRANSPORT; LUNG TRANSPLANTATION; NONHUMAN; PSEUDOMONAS AERUGINOSA; RESPIRATORY TRACT DISEASE; REVIEW; STAPHYLOCOCCUS AUREUS;

BACTERIAL INFECTIONS; BURKHOLDERIA CEPACIA; CYSTIC FIBROSIS; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; HUMANS; LUNG; PSEUDOMONAS AERUGINOSA; RESPIRATORY TRACT INFECTIONS; STAPHYLOCOCCUS AUREUS; TIME FACTORS;

BACTERIA (MICROORGANISMS); BURKHOLDERIA; BURKHOLDERIA CEPACIA; HAEMOPHILUS INFLUENZAE; PSEUDOMONAS; PSEUDOMONAS AERUGINOSA; STAPHYLOCOCCUS AUREUS;

EID: 0032839275     PISSN: 13574310     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1357-4310(99)01506-3     Document Type: Review

References (50)

1. Welsh, M J., Tsui, L.C., Boat, T.F. and Beaudet, A.L. ( 1995) Cystic fibrosis, in The Metabolic and Molecular Bases of Inherited Disease (Scriver, C.R., Beaudet, A.L., Sly, W.S. and Valle, D., eds), pp. 3799-3876, McGraw-Hill
2. Davis, P.B., Drumm, M. and Konstan, M.W. (1996) Cystic fibrosis. Am. J. Respir. Crit. CareMed. 154, 1229-1256
3. Linsdell, P. and Hanrahan, J.W. ( 1998) Glutathione permeability of CFTR, Am. J. Physiol. 275, C323-C326
4. Tümmler, B. and Puchelle, E. (1997) CFTR: a multifaceted epithelial molecule, Trends Cell Biol. 7, 250-251
5. Sheppard, D.N. and Ostedgaard, L.S. (1996) Understanding how cystic fibrosis mutations cause a loss of Cl channel function, Mol. Med. Today 2, 290-297
6. Zahm, J.M. et al. (1997) Early alterations in airway mucociliary clearance and inflammation of the lamina propria in CF mice, Am. J. Physiol. 272, C853-C859
7. Matsui, H. et al. (1998) Evidence for periciliary liquid layer depletion, not abnormal ion composition, in the pathogenesis of cystic fibrosis airways disease, Cell 95, 1005-1017
8. Bastien, L. el al. (1994) Cloning, functional expression, and characterization of the human prostaglandin E2 receptor EP2 subtype, J. Biol. Chem. 269, 11873-11877
9. Khan, T.Z. et al. (1995) Early pulmonary inflammation in infants with cystic fibrosis, 4m. J. Respir. Crit. Care Med. 151, 1075-1082
10. Tabary, 0. etal. (1998) Selective up-regulation of chemokine IL-8 expression in cystic fibrosis bronchial gland cells in vivo and in vitro. Am. J. Paihol. 153, 921-930
11. Gosselin, D. etal. (1998) Impaired ability of Cftr knockout mice to control lung infection with Pseudomonas aeruginosa, Am. J. Respir. Crit. Care Med. 157, 1253-1262
12. Cressman, V.L. et al. (1998) The relationship of chronic mucin secretion to airway disease in normal and CFTR-deficient mice, Am. J. Respir. Cell Mol. Biol. 19, 853-866
13. Pier, G.B. et al (1996) Role of mutant CFTR in hypersusceptibility of cystic fibrosis patients to lung infections. Science 271, 64-67
14. Pier, G.B., Grout, M. and Zaidi, T.S. (1997) Cystic fibrosis transmembrane conductance regulator is an epithelial cell receptor for clearance of Pseudomonas aeruginosa from the lung, Proc. Natl. Acad. Sci. U. S. A. 94, 12088-12093
15. Smith, J.J., Travis, S.M., Greenberg, E.P. and Welsh, M.J. (1996) Cystic fibrosis airway epithelia fail to kill bacteria because of abnormal airway surface fluid, Cell 85, 229-236
16. Goldman, M.J. et al. (1997) Human-defensin-1 is a salt-sensitive antibiotic in lung that is inactivated in cystic fibrosis, Cell 88, 553-560
17. Kubesch, P. et al. (1993) Genetic determinants of airways' colonization with Pseudomonas aeruginosa in cystic fibrosis, Lancet 341, 189-193
18. Frederiksen, B., Lanng, S., Koch, C. and Hoiby, N. (1996) Improved survival in the Danish center-treated cystic fibrosis patients: results of aggressive treatment, Pediatr. Pulmonol. 21, 153-158
19. Johansen, H.K. et al. (1998) Pseudomonas aeruginosa and Burkholderia cepacia infection in cystic fibrosis patients treated in Toronto and Copenhagen, Pediatr. Pulmonol. 26, 89-96
20. Campa, M., Bendindli, M. and Friedman, H., eds (1993) Pseudomonas aemginosa as an Opportunistic Pathogen, Plenum Press
21. Rahme, L.G. etal. (1995) Common virulence factors for bacterial pathogenicity in plants and animals, Science 268, 1899-1902
22. Govan, J.R.W. and Deretic, V. (1996) Microbial pathogenesis in cystic fibrosis: mucoid Pseudomonas aeruginosa and Burkholderia cepacia, Microbiol. Rev. 60, 539-574
23. Baltimore, R.S., Christie, C.D.C. and Smith, G.J.W. (1989) Immunohistopathologic localization of Pseudomonas aeruginosa in lungs from patients with cystic fibrosis. Implication for the pathogenesis of progressive lung deterioration, Am. Rev. Respir. Dis. 140, 1650-1661
24. Römling, U. et al. ( 1994) Epidemiology of chronic Pseudomonas aeruginosa infections in cystic fibrosis, J. Infect Dis. 170, 1616-1621
25. Römling, U., Wingender, J., Müller, W. and Tümmler, B. (1994) A major Pseudomonas aeruginosa clone common to patients and aquatic habitats, AppL Environ. Microbiol. 60, 1734-1738
26. Römling, U., Schmidt, K.D. and Tümmler, B. (1997) Large genome rearrangements discovered by the detailed analysis of 21 Pseudomonas aeruginosa clone C isolates found in environment and disease habitats, J. Mol. Biol. 271, 386-404
27. Boucher, J.C., Yu, H., Mudd, M.H. and Deredc, V. (1997) Mueoid Pseudomonas asruginosa in cystk fibrosis: characterization of mue mutations in clinical isolates and analysis of clearance in a mouse model of respiratory infection. Infect. Immun. 65, 383&-3S46
28. Kubesch, P., von Specht, S.U. and Tümmler, B. (I988) The immune response in cystic fibrosis to outer membrane proteins of Pseudomonas acrnginosa, Zer.tralbl. Bakteriol Hyg. A 269, 395-411!
29. Sokol, P.A. and Woods, D.E. (1984) Relationship of iron and extracellular virulence factors to Pseudomonas aeruginosa lung infections, J. Med. Micrvkiol. 18, 125-133
30. Van Delden, C. and Iglewski, B.H. ( 1998) Cell-to-cell signaling and Pseudomonas aeruginosa infections, Emerg. Infect. Dis. 4, 551-560
31. Davies, D.G. etal. (.998) The involvement of cell-to-cell signals in the development of s bacterial biofilm. Science 280, 295-298
32. FrLnk, D.W. (1997) The exoenzyme S regulon aï Pseudomonas aeruginosa. Mol. Microbiol. 26, 621-629
33. Hauser, A.R., Kang, P.J. and Engel, J.N. (1998) PepA, a secreted protein of Pseudomonas aeruginosa, is necessary for cytotoxicity and virulence. .Mol. MKTO&W. 27, 807-813
34. Burei.A. and Cripps, A.W. (1993) The immunoevasive activities of Pseudomonas aeruginosa: relevance for cystic fibrosis, Am. Rev. Respir. Dis. 148, 793-805
35. Davies. J.C. et ai. (1997) CFTS gene transfer reduces the binding of Pseudomonas aeruginosa to cystic fibrosis respiratory epithelium, Am. j. Respir. CM.Mol.Biol 16, 657-663
36. Bryan, R. et al. ( i 998) Overproduction of CFTR R domain leads to increased levels of asialoGMl and increased Pseudomonas aeruginosa binding to epithelial ceils, Am. J. Respir. Cell. Mol. Biol. 19, 269-277
37. Döring, G. ( 1994) The role of neutrophil elastase in chronic inflammation, Am. J. Respir. Crit. Care Med. 150, 114-H 7
38. Ulrich, M. el al (1998) Localization of Slaphylococcus aureus in infected airways of patients with cystic fibrosis and in a cell culture model of S. aureus adherence, Am. J. Respir. Cell. Mol. Biol. 19, 83-91
39. Heroen, S. et al ( 1997} Regulation of Staphylococcm aureus capsular polysaccharlde type 5: C02 inhibition in vitro and in vivo, J. Infect. Dis. 176, 431-438
40. Kahl, B. e! al. (1998) Persistent Infection with small colony variant strains of Staphylococcus aureui in patienis with cystic fibrosis, J. infect. Dis. 177, 1023-1329
41. Rodley, P.D., Römling, U. and Tümmler, B. (1995) A physical genome map of the Burkholtleria cepacia type strain, Mol. Microbiol. 17, 50-67
42. Vandamme, P. si ai (1Ç97) Occurrence of multiple genomovars ofBurkholderia cepacia in cystic fibrosis patients and proposal of BurkholderUi muitivorans sp. nov., Int. J. Syst. Bacterial. 47, 1188-1200
43. LiPuma, J.J. ( 1998) Burkholderia cspacia. Management issues and new insights, Clin. Chest Me J. 19, 473-486
44. Hutchison, M.L., Poxton, I.R. and Govaa, J.R. (1998) Burkholderia cspacia produces a hemolysin that is capable of inducing apoptosis and degranulation of mammalian phagocytes. Infect. Immun. 66, 2033-2039
45. Wiesemann, H.G. et al. (1998; Placebo-controlled, double-blind, randomized study of aerosolized tobramyein for early treatment of Pseudomonas aeruginosa colonization in cystic fibrosis, Pediatr. Pu'.monol. 25. 88-92
46. Koilberg, H.O., Larsson, A.O. and Carlander, D.O. (1998) More than four years without any new chronic Pseudomonas aeruginosa infections at Uppsala cystic fibrosis center, Pedialr. Palmonol. Suppl. 15.A390
47. Houscon, M.E., Jr, et a!. (1998) Influence of preformed alpha-helix and alphaheiix loduction on the activity of caticnic antimicrobial peptides, J. Pejytic'e Res. 52, 81-88
48. Manefield, M. e! aJ. (1999) Evidence that naiogenated furanones from Delisa pulclira inhibit acylated homoserine lactone (AHL)-mediated gene expression by displacing the AHL signal from its receptor protein, Microbiology 145, 283-291
49. Kudoh, S. et a!. (1998) Erythromycin treatment in diffuse panbronchiolitis, Curr. Opin. Pulmon. Meet. 4, 116-121
50. Coulter, S.N. el al. ( 1998) Staphyiococcus aureus genetic loci impacting growth and survival la multiple infection environments, Mol. Micra'aiol. 30, 393-04